Systematic Literature Review and Indirect Treatment Comparison of Three Ready-to-Use Glucagon Treatments for Severe Hypoglycemia.
Marga GiménezKamlesh KhuntiMunehide MatsuhisaSuresh ChenjiKristen SyringYu YanPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Baqsimi, Gvoke and Zegalogue had comparable high proportions of treatment success in reversing insulin-induced hypoglycemia. Baqsimi achieved a lower mean maximum blood glucose value, which may have implications for the re-establishment of euglycemia. These findings may help support patients, caregivers and health care providers in their decision-making process when discussing various ready-to-use glucagon treatment options.
Keyphrases
- blood glucose
- type diabetes
- glycemic control
- healthcare
- decision making
- end stage renal disease
- ejection fraction
- newly diagnosed
- palliative care
- prognostic factors
- early onset
- diabetic rats
- oxidative stress
- high glucose
- patient reported outcomes
- endothelial cells
- stress induced
- health information
- patient reported
- clinical evaluation